The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TDS, FULC and VIRT

NEW YORK, NY / ACCESSWIRE / June 9, 2023 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Telephone and Data Systems, Inc. (NYSE:TDS)
Class Period: May 6, 2022 - November 3, 2022
Lead Plaintiff Deadline: July 3, 2023

Telephone and Data Systems, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) defendants had no reason to believe UScellular's "free upgrade" promotional activity, which was tested and trialed during the second quarter of 2022, was effective at reducing the UScellular's postpaid churn rate as they represented to investors, as opposed to merely adding new postpaid subscribers, when its churn rate was actually increasing or remaining constant over most quarters in the class period; (ii) UScellular was not making progress with respect to its churn rate, as it represented to investors; (iii) UScellular was not in fact balancing its promotional activity and its profitability; (iv) due to extreme competition among postpaid carriers, UScellular did not have the flexibility to offset the costs from widespread, expensive promotions with price increases; and (v) as a result of the Companies' decision for UScellular to continue engaging in heavy promotions to address its postpaid subscriber churn rate despite any lack of positive impact on churn rate, UScellular's profitability substantially declined.

Learn about your recoverable losses in TDS: https://www.kleinstocklaw.com/pslra-1/tds-lawsuit-loss-submission-form?id=40610&from=1

Fulcrum Therapeutics, Inc. (NASDAQ:FULC)
Class Period: March 3, 2022 - March 8, 2023
Lead Plaintiff Deadline: June 27, 2023

The complaint alleges Fulcrum Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the preclinical data submitted in support of FTX-6058 (an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies) showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in FULC: https://www.kleinstocklaw.com/pslra-1/fulcrum-lawsuit-loss-submission-form?id=40610&from=1

Virtu Financial, Inc. (NASDAQ:VIRT)
Class Period: March 1, 2019 - April 28, 2023
Lead Plaintiff Deadline: July 18, 2023

During the class period, Virtu Financial, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the Company maintained deficient policies and procedures with respect to its information access barriers; (ii) accordingly, Virtu had overstated the Company's operational and technological efficacy as well as its capacity to block the exchange of confidential information between departments or individuals within the Company; (iii) the foregoing deficiencies increased the likelihood that the Company would be subject to enhanced regulatory scrutiny; and (iv) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

Learn about your recoverable losses in VIRT: https://www.kleinstocklaw.com/pslra-1/virtu-lawsuit-loss-submission-form?id=40610&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
535 Fifth Avenue
4th Floor
New York City, NY 10017
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.